hMSCs and all 3 T-ALL cell lines expressed OTC, which means both hMSCs and T-ALL blasts should be capable of converting ornithine into citrulline and eventually recycling L-arginine even under BCT-100 treatment. The gene discussed is OTC; the disease is acute lymphoblastic leukemia.